+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Cancer Pain Management Market by Drug Type (Nerve Blockers, Non-Opioids, Opioids), Route of Administration (Oral, Parental), Application, End-Use - Forecast 2024-2030- Product Image
Global Cancer Pain Management Market by Drug Type (Nerve Blockers, Non-Opioids, Opioids), Route of Administration (Oral, Parental), Application, End-Use - Forecast 2024-2030- Product Image
Sale

Global Cancer Pain Management Market by Drug Type (Nerve Blockers, Non-Opioids, Opioids), Route of Administration (Oral, Parental), Application, End-Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5924846
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cancer Pain Management Market size was estimated at USD 7.42 billion in 2023, USD 7.86 billion in 2024, and is expected to grow at a CAGR of 6.09% to reach USD 11.23 billion by 2030.

Cancer pain management refers to the practices and procedures employed in alleviating pain associated with cancer and its treatment. This multidisciplinary approach is tailored to the patient's needs and encompasses various methods to improve the quality of life for those with cancer. The strategies used for managing cancer-related pain may include pharmacological treatments, such as analgesics and opioids, and non-pharmacological interventions, such as physical therapy, psychological support, and complementary therapies. Effective management of cancer pain is pivotal because it directly impacts a patient's comfort, functioning, and overall well-being.

The rising prevalence of cancer, an aging demographic, technological advancements, regulatory efficiencies, and heightened patient awareness have improved the need for cancer pain management. However, issues arising from the opioid crisis, adverse drug reactions, systemic healthcare disparities, cost barriers, and a lack of comprehensive pain management knowledge may impede market growth. Nevertheless, emerging opportunities within this domain lie in precision drug delivery technologies, increased non-opioid treatment adoption, integrated digital health tools, and the potential of complementary and alternative therapies. Innovation and business expansion are being driven by research into non-addictive analgesics, enhancement of drug delivery mechanisms, pharmacogenetics, and strategic collaborations.

Regional Insights

Patient-centric care models and an emphasis on comprehensive pain management have led to an advanced cancer pain management framework in the Americas. High healthcare expenditure, coupled with extensive insurance coverage, allows for significant adoption of pain management solutions. The regional healthcare system provides substantial support for cancer patients, which includes pain management as a fundamental aspect of care. European Union countries exhibit high variability in cancer pain management approaches due to diverse healthcare systems and differing national policies.

The Middle East and African region is characterized by significant heterogeneity in economic resources, which directly impacts the availability and quality of cancer pain management. The rapidly expanding healthcare system in the Asia-Pacific region has been adapting to the growing prevalence of cancer and its associated pain. Investment in healthcare infrastructure and physician training programs are evident response measures. New policies emphasizing adequate pain control and home-based care have broadened the scope of cancer pain management solutions in Asia-Pacific.

Market Trends by Segment

  • Drug Type: Growing applicability of opioids to treat cancer pain
  • Route of Administration: Growing availability of oral medications for cancer pain management
  • Application: Emerging penetration of cancer pain management solutions for breast cancer
  • End-Use: Elevating usage of cancer pain drugs in hospitals

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

FDA Approves Non-Opioid Painkiller for Mild-to-Moderate Pain

The U.S. Food and Drug Administration (FDA) has given its approval to a new non-opioid medication designed to alleviate mild to moderate pain in cancer patients. This development promises to offer relief without the associated risks of opioid use, such as addiction and overdose. The novel analgesic is poised to become a pivotal component in the pain management regimen, providing a safer alternative for patients and healthcare professionals aiming to mitigate the discomfort caused by cancer while curbing the potential for opioid dependence.

Nevro's (NVRO) Latest Launch to Customize Chronic Pain Treatment

Nevro Corp. announced the introduction of its innovative HFX for PDN solution, signifying a strategic step to tailor its proprietary Senza system to the needs of patients suffering from painful Diabetic Peripheral Neuropathy (PDN). This launch showcases Nevro's commitment to expanding its high-frequency spinal cord stimulation technology for various indications and marks an important milestone in offering more personalized pain treatment options.

Esteve and Medtronic are Collaborating to Address Cancer Pain Patients’ Needs

Esteve, a pharmaceutical company, announced its collaboration with Medtronic, a global pioneer in medical technology, to meet the complex demands of cancer pain patients. This synergistic partnership is focused on delivering innovative solutions to enhance the quality of life for individuals affected by cancer-related pain. Esteve’s expertise in pharmaceuticals and Medtronic’s advanced medical technology are poised to bring forward a new era in pain management.

Key Company Profiles

The report delves into recent significant developments in the Cancer Pain Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Aegis Therapeutics, LLC, Aptinyx Inc., Astellas Pharma Inc., Bausch Health Companies Inc., Baxter International Inc., Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Eisai Co., Ltd., Eli Lilly and Company, Glaxosmithkline PLC, Grünenthal Group, Johnson & Johnson Services, Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Scilex Pharmaceuticals, Teva Pharmaceutical Industries Ltd., and Trevena Inc.

This research report offers invaluable insights into various crucial aspects of the Cancer Pain Management Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of chronic pain and lifestyle disorders worldwide
5.1.1.2. Increasing geriatric population and need for pain-reducing therapies
5.1.2. Restraints
5.1.2.1. Issues associated with product recalls
5.1.3. Opportunities
5.1.3.1. Ongoing product development activities and rising FDA approvals of new products
5.1.3.2. Government funding supporting cancer pain treatments
5.1.4. Challenges
5.1.4.1. Adverse effects associated with cancer pain management drugs
5.2. Market Segmentation Analysis
5.2.1. Drug Type: Growing applicability of opioids to treat cancer pain
5.2.2. Route of Administration: Growing availability of oral medications for cancer pain management
5.2.3. Application: Emerging penetration of cancer pain management solutions for breast cancer
5.2.4. End-Use: Elevating usage of cancer pain drugs in hospitals
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Cancer Pain Management Market, by Drug Type
6.1. Introduction
6.2. Nerve Blockers
6.3. Non-Opioids
6.4. Opioids
7. Cancer Pain Management Market, by Route of Administration
7.1. Introduction
7.2. Oral
7.3. Parental
8. Cancer Pain Management Market, by Application
8.1. Introduction
8.2. Blood Cancer
8.3. Breast Cancer
8.4. Colorectal Cancer
8.5. Lung Cancer
8.6. Prostate Cancer
9. Cancer Pain Management Market, by End-Use
9.1. Introduction
9.2. Home care
9.3. Hospitals
9.4. Specialty Clinics
10. Americas Cancer Pain Management Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cancer Pain Management Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cancer Pain Management Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. FDA Approves Non-Opioid Painkiller for Mild-to-Moderate Pain
13.3.2. Nevro's (NVRO) Latest Launch to Customize Chronic Pain Treatment
13.3.3. Esteve and Medtronic are Collaborating to Address Cancer Pain Patients’ Needs
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. CANCER PAIN MANAGEMENT MARKET RESEARCH PROCESS
FIGURE 2. CANCER PAIN MANAGEMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CANCER PAIN MANAGEMENT MARKET DYNAMICS
FIGURE 7. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 14. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CANCER PAIN MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. CANCER PAIN MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CANCER PAIN MANAGEMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NERVE BLOCKERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NERVE BLOCKERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY FENTANYL, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY FENTANYL, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY MORPHINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY MORPHINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY BLOOD CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY BLOOD CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOME CARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 73. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 74. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 77. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 78. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 79. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 80. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 81. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 82. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 83. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 84. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 87. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 88. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 89. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 90. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 91. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 92. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 93. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 94. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 95. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 96. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 97. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 98. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 99. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 100. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 101. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 102. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 103. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 104. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 105. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 106. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 107. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 108. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 109. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 110. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 111. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 114. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 115. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 116. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 117. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 118. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 119. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 120. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 121. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 122. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 123. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 126. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 127. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 128. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 130. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 132. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 134. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 136. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 140. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 142. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 143. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 144. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 145. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 146. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 147. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 148. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 149. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 150. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 151. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 152. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 153. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 154. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 155. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 156. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 157. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 158. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 159. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 160. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 161. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 162. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 163. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 166. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 167. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 168. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 169. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 170. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 171. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 172. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 173. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 174. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 175. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 178. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 179. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 180. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 181. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 182. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 183. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 184. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 185. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 186. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 187. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 190. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 191. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 192. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 193. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 194. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 195. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 196. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 197. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 198. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 199. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 202. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 203. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 204. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 205. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 206. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 207. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 208. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 209. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 210. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 211. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 212. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 213. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 214. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 215. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 216. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 217. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 218. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 219. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 220. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 221. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 222. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 223. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 224. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 225. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 226. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 227. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 228. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 229. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 230. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 231. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 232. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 233. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 234. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 235. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 238. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 239. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 240. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 241. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 242. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 243. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 244. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 245. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 246. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 247. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 248. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 249. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 250. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 251. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 252. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 253. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 254. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 255. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 256. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 257. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 258. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 259. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 262. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 263. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 264. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 265. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 266. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 267. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 268. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 269. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 270. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 271. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 272. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 273. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 274. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 275. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 276. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 277. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 278. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 279. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 280. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 281. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 282. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 283. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 284. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 285. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 286. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 301. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 302. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 303. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 304. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 305. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 306. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 307. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 308. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 309. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 310. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 311. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 312. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 313. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 314. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 315. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 316. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 317. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 318. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 319. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 320. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 321. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 322. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 323. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 324. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 325. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 326. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 327. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
TABLE 328. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
TABLE 329. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
TABLE 330. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
TABLE 331. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 332. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 333. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 334. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 335. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 336. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 337. FRANCE CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-20

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • Aegis Therapeutics, LLC
  • Aptinyx Inc.
  • Astellas Pharma Inc.
  • Bausch Health Companies Inc.
  • Baxter International Inc.
  • Bayer AG
  • Biogen Inc.
  • Boehringer Ingelheim International GmbH
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Glaxosmithkline PLC
  • Grünenthal Group
  • Johnson & Johnson Services, Inc.
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • Sanofi SA
  • Scilex Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.
  • Trevena Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages181
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 7.86 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.23 Billion
Compound Annual Growth Rate6.0%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Analgesics Market Size, Share & Trends Analysis Report By Drug Type (Opioid, Non-opioid, Compound Medication), By Route Of Administration, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2023-2030 - Product Image

Analgesics Market Size, Share & Trends Analysis Report By Drug Type (Opioid, Non-opioid, Compound Medication), By Route Of Administration, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2023-2030

  • Report
  • 150 Pages
  • Global
From
Global Pain Management Therapeutics Market by Therapeutics (Anesthetics, Anticonvulsants, Antidepressants), Indication (Arthritic Pain, Cancer Pain, Chronic Back Pain), Distribution Channel - Forecast 2024-2030 - Product Image

Global Pain Management Therapeutics Market by Therapeutics (Anesthetics, Anticonvulsants, Antidepressants), Indication (Arthritic Pain, Cancer Pain, Chronic Back Pain), Distribution Channel - Forecast 2024-2030

  • Report
  • 199 Pages
  • Global
From
Non-opioid Pain Patch - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Non-opioid Pain Patch - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • Global
From
Opioid Market Size, Share & Trends Analysis Report By Product (IR/ Short Acting Opioids, ER/Long-Acting Opioids), By Application (Pain Relief, Anesthesia), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Opioid Market Size, Share & Trends Analysis Report By Product (IR/ Short Acting Opioids, ER/Long-Acting Opioids), By Application (Pain Relief, Anesthesia), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 120 Pages
  • Global
From
Pain Management Drugs Global Market Report 2024 - Product Image

Pain Management Drugs Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.